Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 15;205(4):680-3.
doi: 10.1093/infdis/jir806. Epub 2011 Dec 22.

The first Plasmodium vivax relapses of life are usually genetically homologous

Affiliations

The first Plasmodium vivax relapses of life are usually genetically homologous

Mallika Imwong et al. J Infect Dis. .

Abstract

In a prospective infant cohort, 21 infants developed Plasmodium vivax malaria during their first year. Twelve of their mothers also had vivax malaria in the corresponding pregnancies or postpartum period. The genotypes of the maternal and infant infections were all different. Eight of the 12 mothers and 9 of the 21 infants had recurrent infections. Relapse parasite genotypes were different to the initial infection in 13 of 20 (65%) mothers compared with 5 of 24 (21%) infants (P = .02). The first P. vivax relapses of life are usually genetically homologous, whereas relapse in adults may result from activation of heterologous latent hypnozoites acquired from previous inoculations.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Temporal pattern and genotyping of recurrences of Plasmodium vivax malaria in 8 mothers (A) and 9 infants (B). Each number on the y-axis represents a patient. Filled circles denote the initial infection. An open circle represents a genetically homologous recurrence, and a black diamond represents a genetically heterologous recurrence. Recurrences where genotyping was indeterminate (2 in infants, 3 in mothers) are not shown. One mother’s sole relapse was indeterminate.

Comment in

References

    1. Looareesuwan S, Wilairatana P, Krudsood S, et al. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol. 1999;93:225–30. - PubMed
    1. Luxemburger C, van Vugt M, Jonathan S, et al. Treatment of vivax malaria on the western border of Thailand. Trans R Soc Trop Med Hyg. 1999;93:433–8. - PubMed
    1. Silachamroon U, Krudsood S, Treeprasertsuk S, et al. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg. 2003;69:14–18. - PMC - PubMed
    1. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010;10:673–81. - PMC - PubMed
    1. Douglas NM, Nosten F, Ashley EA, et al. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011;52:612–20. - PMC - PubMed

Publication types